CCA CATO Associate Investigational Product Management 2

Question 1

What is the purpose of a drug reconciliation at the end of a clinical trial?

Accepted Answer

To verify that all dispensed, returned, and destroyed IP quantities balance with what was received

Answer

Drug reconciliation confirms that all IP received is accounted for through dispensing records, subject returns, and destruction documentation.

Question 2

What is a 'medication error' in the context of investigational product management?

Accepted Answer

Any unintended exposure of a subject to the wrong IP dose, route, or product

Answer

A medication error is any unintended deviation in the administration of IP—wrong dose, wrong route, wrong subject, or wrong product.

Question 3

What does 'blinded randomization' require of the IP packaging and labeling?

Accepted Answer

Active and placebo must be indistinguishable in appearance and labeled with only a randomization code

Answer

Blinded trial packaging requires active and placebo to look identical, with labels bearing only a code so that neither site staff nor subjects can identify the treatment.

Question 4

Under GCP, how long must IP accountability records typically be retained after the trial ends?

Accepted Answer

Per sponsor/regulatory requirements, typically at least 2–15 years depending on jurisdiction

Answer

IP accountability records must be retained per applicable regulatory requirements and sponsor instructions, commonly ranging from 2 to 15+ years.

Question 5

When a clinical site receives a shipment of investigational product, what should be done first?

Accepted Answer

Inspect the shipment, verify contents against the packing list, and check storage conditions were maintained during transit

Answer

Upon IP receipt, the site must inspect the shipment for damage, verify quantities against the packing list, and confirm transit temperature logs before accepting the product.

(CCA) CATO Certified Associate Practice Test

(CCA) CATO Certified Associate Practice Test

CCA CATO Associate Investigational Product Management 2